- The Efficacy of High-dose Melphalan with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma
-
Lee JL, Kim SB, Lee GW, Ryu MH, Kim EK, Kim S, Kim WK, Lee JS, Kim SH, Suh CW
- KMID: 2428346
- Yonsei Med J.
- 2003 Oct;44(5):800-810.
Although high-dose therapy (HDT) with autologous hematopoietic stem cell transplantation (ASCT) is widely accepted as an effective and safe consolidation therapy for multiple myeloma (MM), few reports on its efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Value of Post-Transplant Bone Marrow Plasma Cell Percent in Multiple Myeloma Patients Undergone Autologous Transplantation
-
Hwang IH, Chung JS, Shin HJ, Choi YJ, Song MK, Seol YM, Cho GJ, Choi BG, Choi MK, Choi BK, Ahn KH, Shin KH, Lee HS, Nam HS, Hwang JM
- KMID: 1036154
- Korean J Intern Med.
- 2011 Mar;26(1):76-81.
- doi: 10.3904/kjim.2011.26.1.76
BACKGROUND/AIMS: Autologous stem cell transplantation (ASCT) has become the treatment of choice for patients with multiple myeloma (MM). Studies have shown that maintenance treatment with interferon-alpha is associated with improved... -
- CITED
-
- Close
- SHARE
-
- Close
